Radost Vatcheva

Resistance to therapy caused by intragenic deletion in BRCA2

Stacey L. Edwards, Rachel Brough, Christopher J. Lord et al. · Nature · 2008 · 979 citations

Intragenic Deletion, Oncogenic Agent, Pathology +4

Large-scale chromatin organization of the major histocompatibility complex and other regions of human chromosome 6 and its response to interferon in interphase nuclei

Emanuela V. Volpi, Edith Chevret, T. Alwyn Jones et al. · Journal of Cell Science · 2000 · 432 citations

Genetics, Epigenetics, Transcriptional Regulation +19

PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors

Konstantin J. Dedes, Daniel Wetterskog, Ana M. Mendes‐Pereira et al. · Science Translational Medicine · 2010 · 252 citations

Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas

Felipe C. Geyer, Britta Weigelt, Rachael Natrajan et al. · The Journal of Pathology · 2009 · 246 citations

Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers

Rachael Natrajan, Maryou B. Lambros, Socorro Marıá Rodríguez-Pinilla et al. · Clinical Cancer Research · 2009 · 167 citations